Magnetic Control of Polymorphism in Pharmaceutical Compounds

Project Information

MagnaPharm

Grant agreement ID: 736899

DOI 10.3030/736899

Closed project

EC signature date 13 December 2016

Start date 1 January 2017

End date 30 June 2021

Funded under

• EXCELLENT SCIENCE - Future and Emerging Technologies (FET)

Total cost € 2 886 323,75

EU contribution € 2 886 323,75

Coordinated by

UNIVERSITY OF BRISTOL
United Kingdom

• Directed polymorphism may lead to better treatments
  EN